Elaine Tuomanen | Academic Influence

Elaine Tuomanen's AcademicInfluence.com Rankings

Elaine Tuomanen

Biology

#1929

World Rank

#3115

Historical Rank

Microbiology

#152

World Rank

#182

Historical Rank

biology Degrees

Download Badge

Biology

Elaine Tuomanen's Degrees

Bachelors Biology University of California, Santa Cruz
Masters Medicine University of California, San Francisco

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2025

Why Is Elaine Tuomanen Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Elaine I. Tuomanen is an American pediatrician and chair of the Department of Infectious Diseases at St. Jude Children's Research Hospital. She is noted for her research on Molecular pathogenesis of Streptococcus pneumoniae.

(See a Problem?)

Elaine Tuomanen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. (1999) (1401)
Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses (1995) (1295)
Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor (1995) (768)
Toll-like receptor–induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens (2008) (594)
The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth. (1986) (476)
The Polymeric Immunoglobulin Receptor Translocates Pneumococci across Human Nasopharyngeal Epithelial Cells (2000) (414)
Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway. (1998) (407)
The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis (1990) (390)
The induction of meningeal inflammation by components of the pneumococcal cell wall. (1985) (368)
Use of a Whole Genome Approach To Identify Vaccine Molecules Affording Protection against Streptococcus pneumoniae Infection (2001) (361)
Emergence of vancomycin tolerance in Streptococcus pneumoniae (1999) (356)
Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway (1996) (352)
The pneumococcus: epidemiology, microbiology, and pathogenesis. (2013) (350)
Recognition of a bacterial adhesin by an integrin: Macrophage CR3 (α M β 2, CD11b CD18 ) binds filamentous hemagglutinin of Bordetella pertussis (1990) (349)
Pathogenesis of pneumococcal infection. (1995) (341)
Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes (1989) (332)
Pneumococcal pneumolysin and H(2)O(2) mediate brain cell apoptosis during meningitis. (2002) (331)
Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role in adherence. (1989) (325)
Antibiotic tolerance among clinical isolates of bacteria (1986) (324)
Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. (2004) (322)
Neuroprotection by a caspase inhibitor in acute bacterial meningitis (1999) (278)
Role of Novel Choline Binding Proteins in Virulence of Streptococcus pneumoniae (2000) (272)
Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models. (2009) (269)
Microarray Analysis of Pneumococcal Gene Expression during Invasive Disease (2004) (256)
The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis. (1985) (250)
Characterization of two adhesins of Bordetella pertussis for human ciliated respiratory-epithelial cells. (1985) (210)
Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cells (2003) (200)
Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization (1991) (191)
Identification of a Candidate Streptococcus pneumoniae Core Genome and Regions of Diversity Correlated with Invasive Pneumococcal Disease (2006) (187)
Neural Targeting of Mycobacterium leprae Mediated by the G Domain of the Laminin-α2 Chain (1997) (181)
Evaluation of the bactericidal activity of beta-lactam antibiotics on slowly growing bacteria cultured in the chemostat (1986) (181)
Relationship between colonial morphology and adherence of Streptococcus pneumoniae (1995) (174)
Production of interleukin-1 but not tumor necrosis factor by human monocytes stimulated with pneumococcal cell surface components (1989) (168)
The murein hydrolases of Escherichia coli: properties, functions and impact on the course of infections in vivo. (1991) (168)
Phenotypic tolerance: the search for beta-lactam antibiotics that kill nongrowing bacteria. (1986) (166)
Streptococcus pneumoniae Translocates into the Myocardium and Forms Unique Microlesions That Disrupt Cardiac Function (2014) (156)
Consequences of microbial attachment: directing host cell functions with adhesins (1992) (151)
Nonsteroidal anti-inflammatory agents in the therapy for experimental pneumococcal meningitis. (1987) (151)
Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. (2010) (145)
Pertussis toxin has eukaryotic-like carbohydrate recognition domains. (1992) (142)
Apoptosis-inducing factor mediates microglial and neuronal apoptosis caused by pneumococcus. (2001) (140)
Control of Virulence by Small RNAs in Streptococcus pneumoniae (2012) (138)
Role of the manganese efflux system mntE for signalling and pathogenesis in Streptococcus pneumoniae (2009) (135)
Preinfection systemic inflammatory markers and risk of hospitalization due to pneumonia. (2005) (135)
Oligosaccharides interfere with the establishment and progression of experimental pneumococcal pneumonia. (1997) (133)
Induction of pulmonary inflammation by components of the pneumococcal cell surface. (2015) (130)
Receptor analogs and monoclonal antibodies that inhibit adherence of Bordetella pertussis to human ciliated respiratory epithelial cells (1988) (130)
Recognition of a bacterial adhesion by an integrin: macrophage CR3 (alpha M beta 2, CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis. (1990) (128)
Pneumococcal licD2 gene is involved in phosphorylcholine metabolism (1999) (127)
Receptor specificity of adherence of Streptococcus pneumoniae to human type-II pneumocytes and vascular endothelial cells in vitro. (1994) (125)
Penicillin tolerance genes of Streptococcus pneumoniae: the ABC‐type manganese permease complex Psa (1998) (121)
Adherence of Streptococcus pneumoniae to immobilized fibronectin (1995) (119)
Host–pathogen interactions in bacterial meningitis (2016) (118)
Ligand specificity of purified complement receptor type three (CD11b/CD18, alpha m beta 2, Mac-1). Indirect effects of an Arg-Gly-Asp (RGD) sequence. (1993) (117)
Recognition of pneumococcal peptidoglycan: an expanded, pivotal role for LPS binding protein. (2003) (116)
β-Arrestin 1 Participates in Platelet-Activating Factor Receptor-Mediated Endocytosis of Streptococcus pneumoniae (2005) (115)
Differing roles for platelet-activating factor during inflammation of the lung and subarachnoid space. The special case of Streptococcus pneumoniae. (1992) (114)
Entry of pathogens into the central nervous system. (1996) (113)
Relationship between phase variation in colony morphology, intrastrain variation in cell wall physiology, and nasopharyngeal colonization by Streptococcus pneumoniae (1996) (113)
Statins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell disease. (2010) (112)
Virulence in mice of pneumococcal clonal types with known invasive disease potential in humans. (2005) (112)
Molecular and cellular biology of pneumococcal infection. (1999) (106)
Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin. (2001) (104)
The cell wall mediates pneumococcal attachment to and cytopathology in human endothelial cells (1993) (104)
Molecular pathogenesis of pneumococcal pneumonia. (2001) (103)
Signal transduction by a death signal peptide: uncovering the mechanism of bacterial killing by penicillin. (2000) (97)
Serum Immunoglobulin G Response to Candidate Vaccine Antigens during Experimental Human Pneumococcal Colonization (2003) (92)
Gut Microbiome Composition Predicts Infection Risk During Chemotherapy in Children With Acute Lymphoblastic Leukemia (2018) (90)
Capsular expression in Streptococcus pneumoniae negatively affects spontaneous and antibiotic-induced lysis and contributes to antibiotic tolerance. (2004) (88)
Dual phases of apoptosis in pneumococcal meningitis. (2004) (88)
Role of carbohydrate recognition domains of pertussis toxin in adherence of Bordetella pertussis to human macrophages (1992) (88)
The TLR2‐MyD88‐NOD2‐RIPK2 signalling axis regulates a balanced pro‐inflammatory and IL‐10‐mediated anti‐inflammatory cytokine response to Gram‐positive cell walls (2008) (87)
Reprogramming the Host Response in Bacterial Meningitis: How Best To Improve Outcome? (2003) (87)
Toll-like receptor 2 mediates fatal immunopathology in mice during treatment of secondary pneumococcal pneumonia following influenza. (2011) (86)
Platelet-Activating Factor Receptor and Innate Immunity: Uptake of Gram-Positive Bacterial Cell Wall into Host Cells and Cell-Specific Pathophysiology (2006) (86)
Identification of a carbohydrate recognition domain in filamentous hemagglutinin from Bordetella pertussis (1993) (84)
Identification of a Streptococcus pneumoniae Gene Locus Encoding Proteins of an ABC Phosphate Transporter and a Two-Component Regulatory System (1999) (83)
Calcium efflux is essential for bacterial survival in the eukaryotic host (2008) (82)
Pathogenesis of pneumococcal pneumonia. (1999) (82)
Progression of hearing loss in experimental pneumococcal meningitis: correlation with cerebrospinal fluid cytochemistry. (1993) (80)
Organ-specific models of Streptococcus pneumoniae Disease (2003) (78)
Type I Interferon Protects against Pneumococcal Invasive Disease by Inhibiting Bacterial Transmigration across the Lung (2013) (77)
The molecular basis of pneumococcal infection: a hypothesis. (1995) (75)
Mechanisms of antibiotic resistance and tolerance in Streptococcus pneumoniae. (2000) (74)
Differences of pathophysiology in experimental meningitis caused by three strains of Streptococcus pneumoniae. (1991) (71)
Multifunctional Role of Choline Binding Protein G in Pneumococcal Pathogenesis (2006) (71)
Influence of Neutropenia on the Course of Serotype 8 Pneumococcal Pneumonia in Mice (2007) (71)
Hearing loss and pneumococcal meningitis: An animal model (1991) (70)
Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion protein. (2014) (70)
Coexistence of CD14-dependent and independent pathways for stimulation of human monocytes by gram-positive bacteria (1997) (69)
Microbiological and clinical significance of a new property of defective lysis in clinical strains of pneumococci. (1988) (69)
The Role of N-Glycosylation for Functional Expression of the Human Platelet-activating Factor Receptor (1995) (68)
Vancomycin Stress Response in a Sensitive and a Tolerant Strain of Streptococcus pneumoniae (2005) (68)
A structure-activity relationship for induction of meningeal inflammation by muramyl peptides. (1993) (67)
Dynamic capsule restructuring by the main pneumococcal autolysin LytA in response to the epithelium (2016) (67)
Cellular damage in bacterial meningitis: An interplay of bacterial and host driven toxicity (2007) (66)
The Biology of Pneumococcal Infection (1997) (65)
The role of complement in inflammation during experimental pneumococcal meningitis. (1986) (64)
Streptococcus pneumoniae: Invasion and Inflammation. (2019) (63)
Oral chloramphenicol in the treatment of Haemophilus influenzae meningitis. (1981) (62)
Penicillin-binding protein 7 and its relationship to lysis of nongrowing Escherichia coli (1987) (61)
The contribution of pneumococcal cell wall to the pathogenesis of experimental otitis media. (1988) (61)
Regulation of growth inhibition at high temperature, autolysis, transformation and adherence in Streptococcus pneumoniae by ClpC (2000) (60)
Molecular and cellular mechanisms for microbial entry into the CNS. (1999) (60)
Early biofilm formation on microtiter plates is not correlated with the invasive disease potential of Streptococcus pneumoniae. (2010) (60)
Species specificity of Bordetella adherence to human and animal ciliated respiratory epithelial cells (1983) (60)
Adherence of Bordetella pertussis to human respiratory epithelial cells. (1983) (59)
Pathogenesis of pneumococcal inflammation: otitis media. (2000) (59)
Innate sensors for Gram-positive bacteria. (2003) (59)
Cytokine secretion requires phosphatidylcholine synthesis (2008) (59)
PAf receptor anchors Streptococcus pneumoniae to activated human endothelial cells. (1996) (59)
Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma. (2009) (58)
Convergence of Regulatory Networks on the Pilus Locus of Streptococcus pneumoniae (2008) (58)
RelA Mutant Enterococcus faecium with Multiantibiotic Tolerance Arising in an Immunocompromised Host (2017) (58)
Changes in peptidoglycan composition and penicillin-binding proteins in slowly growing Escherichia coli (1987) (58)
Autolysis-resistant peptidoglycan of anomalous composition in amino-acid-starved Escherichia coli (1988) (55)
Piracy of adhesins: attachment of superinfecting pathogens to respiratory cilia by secreted adhesins of Bordetella pertussis (1986) (55)
Newly made enzymes determine ongoing cell wall synthesis and the antibacterial effects of cell wall synthesis inhibitors (1986) (55)
Coordinate regulation of beta-lactamase induction and peptidoglycan composition by the amp operon. (1991) (54)
Breaching the blood-brain barrier. (1993) (54)
Bacterial Peptidoglycan Traverses the Placenta to Induce Fetal Neuroproliferation and Aberrant Postnatal Behavior (2016) (53)
Induction of procoagulant activity on human endothelial cells by Streptococcus pneumoniae (1992) (53)
Serotype-related differences in inflammatory response to Streptococcus pneumoniae in experimental meningitis. (1997) (53)
Genomic analyses of pneumococci from children with sickle cell disease expose host-specific bacterial adaptations and deficits in current interventions. (2014) (53)
Placebo-controlled double-blind evaluation of trimethoprim-sulfamethoxazole treatment of Yersinia enterocolitica gastroenteritis. (1984) (51)
Transglycosylase and endopeptidase participate in the degradation of murein during autolysis of Escherichia coli (1986) (51)
Cell Wall-Mediated Neuronal Damage in Early Sepsis (2006) (51)
Extracellular targeting of choline‐binding proteins in Streptococcus pneumoniae by a zinc metalloprotease (2000) (50)
Interplay of Pneumococcal Hydrogen Peroxide and Host-Derived Nitric Oxide (2006) (48)
A Multicenter Consortium to Define the Epidemiology and Outcomes of Inpatient Respiratory Viral Infections in Pediatric Hematopoietic Stem Cell Transplant Recipients (2017) (48)
Pneumolysin: Pathogenesis and Therapeutic Target (2020) (46)
Mechanism of phenotypic tolerance of nongrowing pneumococci to beta-lactam antibiotics. (1990) (44)
Tolerance to vancomycin in pneumococci: detection with a molecular marker and assessment of clinical impact. (2004) (44)
Unencapsulated Streptococcus pneumoniae from conjunctivitis encode variant traits and belong to a distinct phylogenetic cluster (2014) (44)
Filamentous hemagglutinin and pertussis toxin promote adherence of Bordetella pertussis to cilia. (1985) (44)
Revising the Role of the Pneumococcal vex-vncRS Locus in Vancomycin Tolerance (2004) (44)
Erythromycin in treatment of Campylobacter enteritis in children. (1983) (43)
Characterization of antibody inhibiting adherence of Bordetella pertussis to human respiratory epithelial cells (1984) (42)
IgG1+ B‐cell immunity predates IgE responses in epicutaneous sensitization to foods (2018) (42)
Penetration of the blood-brain barrier: enhancement of drug delivery and imaging by bacterial glycopeptides (1995) (40)
Bacterial components and the pathophysiology of injury to the blood-brain barrier: does cell wall add to the effects of endotoxin in gram-negative meningitis? (1992) (40)
Attachment factors of Bordetella pertussis: mimicry of eukaryotic cell recognition molecules. (1993) (39)
Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection (2015) (39)
Induction of autolysis in nongrowing Escherichia coli (1986) (38)
Prokaryotic peptides that block leukocyte adherence to selectins (1993) (38)
Inhibition of T Cells Provides Protection against Early Invasive Pneumococcal Disease (2010) (38)
A live-attenuated pneumococcal vaccine elicits CD4+ T-cell dependent class switching and provides serotype independent protection against acute otitis media (2013) (38)
Pharmacokinetics of fluconazole in cerebrospinal fluid and serum of rabbits: validation of an animal model used to measure drug concentrations in cerebrospinal fluid (1994) (37)
Modulation of bacteriolysis by cooperative effects of penicillin-binding proteins 1a and 3 in Escherichia coli (1986) (37)
Antiinflammatory effects in experimental meningitis of prokaryotic peptides that mimic selectins. (1993) (37)
Bacterial Inhibition of Phosphatidylcholine Synthesis Triggers Apoptosis in the Brain (2004) (36)
A sandwich adhesin on Streptococcus pneumoniae attaching to human oropharyngeal epithelial cells in vitro (1988) (34)
The impact of dexamethasone on hearing loss in experimental pneumococcal meningitis. (1995) (34)
Hypersusceptibility to invasive pneumococcal infection in experimental sickle cell disease involves platelet-activating factor receptor. (2007) (34)
Pneumococcal cell wall activates NF-κB in human monocytes: aspects distinct from endotoxin (1996) (34)
Pneumococcal pathogenesis: “innate invasion” yet organ-specific damage (2010) (33)
The pathophysiology of pneumococcal meningitis. (1994) (30)
Noninvasive Monitoring of Pneumococcal Meningitis and Evaluation of Treatment Efficacy in an Experimental Mouse Model* (2005) (29)
Reversible opening of the blood-brain barrier by anti-bacterial antibodies. (1993) (29)
Effect of thalidomide on the inflammatory response in cerebrospinal fluid in experimental bacterial meningitis. (1995) (28)
The p53-Target Gene Puma Drives Neutrophil-Mediated Protection against Lethal Bacterial Sepsis (2010) (28)
The biologic activities of peptidoglycan in experimental Haemophilus influenzae meningitis. (1993) (28)
A Perfect Storm: Increased Colonization and Failure of Vaccination Leads to Severe Secondary Bacterial Infection in Influenza Virus-Infected Obese Mice (2017) (28)
SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8 T cells (2022) (27)
Hydroxyurea therapy of a murine model of sickle cell anemia inhibits the progression of pneumococcal disease by down-modulating E-selectin. (2012) (27)
Molecular mechanisms of inflammation in experimental pneumococcal meningitis (1987) (26)
AdcAII of Streptococcus pneumoniae Affects Pneumococcal Invasiveness (2016) (25)
Molecular and Cellular Mechanisms of Pneumococcal Meningitis (1996) (25)
Assessment of molecular typing methods to determine invasiveness and to differentiate clones of Streptococcus pneumoniae. (2007) (24)
β-Arrestin 1 Participates in Platelet-Activating Factor Receptor-Mediated Endocytosis of Streptococcus pneumoniae (2006) (23)
Partner drugs: a new outlook for bacterial meningitis. (1988) (23)
Molecular mechanisms of brain damage in bacterial meningitis. (1999) (23)
Planning and Implementation of an Infection Control Training Program for Healthcare Providers in Latin America (2007) (22)
Role of autolysins in the activities of imipenem and CGP 31608, a novel penem, against slowly growing bacteria (1989) (21)
Correlation Between the Interval of Influenza Virus Infectivity and Results of Diagnostic Assays in a Ferret Model. (2016) (21)
Cerebral cell adhesion molecule: a novel leukocyte adhesion determinant on blood-brain barrier capillary endothelium. (2000) (20)
Unusual composition of peptidoglycan in Bordetella pertussis. (1989) (20)
Catecholamine norepinephrine diminishes lung epithelial cell adhesion of Streptococcus pneumoniae by binding iron. (2013) (20)
Lectin domains in the toxin ofBordetella pertussis: selectin mimicry linked to microbial pathogenesis (1994) (18)
Peptide from a prokaryotic adhesin blocks leukocyte migration in vitro and in vivo. (1995) (18)
Characterization of a recombinant fragment that contains a carbohydrate recognition domain of the filamentous hemagglutinin (1997) (17)
Bacterial Peptidoglycan Traverses the Placenta to Induce Fetal Neuroproliferation and Aberrant Postnatal Behavior. (2016) (16)
Induction of meningeal inflammation by diverse bacterial cell walls (1986) (16)
Host cell invasion by Streptococcus pneumoniae. (2000) (16)
State-of-the-art in the pneumococcal field: Proceedings of the 11th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD-11) (2020) (15)
A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation. (2008) (15)
Pneumococcal neuraminidase activates TGF-β signalling (2017) (15)
Composition of the peptidoglycan of Haemophilus influenzae. (1993) (14)
Vancomycin-tolerant Streptococcus pneumoniae and its clinical significance. (2001) (13)
Contribution of Pneumococcal Cell Wall to Experimental Otitis Media Pathogenesis (1988) (13)
New antibodies as adjunctive therapies for Gram-positive bacterial meningitis. (1989) (13)
Molecular analysis of antibiotic tolerance in pneumococci. (2002) (12)
Dissecting Bacterial Cell Wall Entry and Signaling in Eukaryotic Cells: an Actin-Dependent Pathway Parallels Platelet-Activating Factor Receptor-Mediated Endocytosis (2017) (12)
Pneumococcal cell wall activates NF-kappa B in human monocytes: aspects distinct from endotoxin. (1996) (12)
Exogenous remodeling of lung resident macrophages protects against infectious consequences of bone marrow-suppressive chemotherapy (2016) (11)
Susceptibility to infection and age-related changes in the blood-brain barrier (1994) (11)
Molecular and cellular biology of pneumococcal infection. (1997) (11)
Staphylococcal protein A adsorption of neonatal serum to facilitate early diagnosis of congenital infection. (1980) (11)
Surprise? Bacteria glycosylate proteins too. (1996) (11)
Interactions of bacteria with leukocyte integrins. (1994) (11)
A spoonful of sugar to control inflammation? (1994) (11)
Perspective: targeting nitric oxide in the adjuvant therapy of sepsis and meningitis. (1998) (10)
The vir locus affects the response of Bordetella pertussis to antibiotics: phenotypic tolerance and control of autolysis. (1990) (10)
Cephalosporin-resistant Pneumococci and Sickle Cell Disease (2005) (10)
The mystery of psaA and penicillin tolerance in Streptococcus pneumoniae (2000) (9)
Modulation of inflammation in bacterial meningitis. (1994) (9)
Adjunctive therapy of experimental meningitis: agents other than steroids. (1992) (9)
Appreciating Our Usual Guests (2005) (9)
Attachment and Invasion of the Respiratory Tract (2004) (9)
Models of pneumococcal disease (2006) (9)
Peptides from pertussis toxin interfere with neutrophil adherence in vitro and counteract inflammation in vivo. (1994) (9)
Protection by D-amino acids against growth inhibition and lysis caused by beta-lactam antibiotics (1984) (8)
Adhesion of microbial pathogens to leukocyte integrins: methods to study ligand mimicry. (1995) (8)
Cross-reactive Antibody Response to mRNA SARS-CoV-2 Vaccine After Recent COVID-19-Specific Monoclonal Antibody Therapy (2021) (8)
The Surface of Mammalian Respiratory Cilia Interactions between Cilia and Respiratory Pathogens (1990) (8)
Development of anti-adhesion carbohydrate drugs for clinical use. (1996) (8)
Antibiotic tolerance among clinical isolates of bacteria. (1986) (8)
Antibiotics which kill nongrowing bacteria (1987) (8)
A Cross-Reactive Protein Vaccine Combined with PCV-13 Prevents Streptococcus pneumoniae- and Haemophilus influenzae-Mediated Acute Otitis Media (2019) (7)
Multi-Valent Protein Hybrid Pneumococcal Vaccines: A Strategy for the Next Generation of Vaccines (2021) (7)
Erratum: β-arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae (Infection and Immunity (2005) 73, 12 (7827-7835)) (2006) (6)
PGRPs kill with an ancient weapon (2011) (6)
Inhibition of the binding of penicillin to the pneumococcal penicillin-binding proteins (PBPs) by exogenous cell wall peptides. (1989) (6)
A sandwich adhesion on Streptococcus pneumoniae attaching to human oropharyngeal epithelial cells in vitro. (1988) (6)
Pneumococcal Invasion: Development of Bacteremia and Meningitis (2015) (6)
Recombinant microbial ADP-ribosylating toxins of Bordetella pertussis, Vibrio cholerae, and enterotoxigenic Escherichia coli: structure, function, and toxoid vaccine development. (1994) (6)
Mediators of inflammation and the treatment of bacterial meningitis (1995) (5)
Adapting a diet from sugar to meat: double‐dealing genes of Streptococcus pyogenes (2007) (5)
Adjuncts to the therapy of bacterial meningitis. (1990) (4)
Antibiotic prophylaxis and the gastrointestinal resistome in paediatric patients with acute lymphoblastic leukaemia: a cohort study with metagenomic sequencing analysis (2021) (4)
Acute Bacterial Meningitis: Challenges to Better Antibiotic Therapy. (2019) (3)
Caging and COM-Bating Antibiotic Resistance. (2020) (3)
Host Predictors of Broadly Cross-Reactive Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern Differ Between Infection and Vaccination (2021) (3)
Blood borne: bacterial components in mother’s blood influence fetal development (2016) (3)
BIOLOGY OF ADHESINS OF BORDETELLA PERTUSSIS: INTEGRINS, SELECTINS, AND MIMICRY OF LEUKOCYTE ADHERENCE TO ENDOTHELIA (1992) (3)
Coexistence of CD 14-Dependent and Independent Pathways for Stimulation of Human Monocytes by Gram-Positive Bacteria (1997) (3)
Chapter 40 – Bacterial Interactions with Mucosal Epithelial Cells (2005) (2)
Radionuclide joint imaging: acute rheumatic fever simulating septic arthritis. (1980) (2)
Epidemiology of Respiratory Viral Infections in Pediatric Solid Organ Transplant or Hematopoietic Stem Cell Transplant Recipients (2015) (2)
Can microbial pathogenesis team up with immunology? (1995) (2)
Pneumococcal Surface Protein A Plays a Major Role in Streptococcus pneumoniae–Induced Immunosuppression (2016) (2)
Advances in the diagnosis and management of bacterial meningitis (1990) (2)
Consequences ofMicrobial Attachment: Directing Host CellFunctions withAdhesins (1992) (2)
Mini-Review: Bioactivities of Bacterial Cell Envelopes in the Central Nervous System (2020) (2)
Bacterial Interactions with Mucosal Epithelial Cells (2015) (2)
Streptococcus pneumoniae: The Prototype of Lung Responses in Pneumonia (2013) (1)
Unveiling Unexpected Immune Activities Induced by Your Pneumococcal Vaccine (2016) (1)
Divergence in the background: hard to measure but the key to being the best of the best. (1999) (1)
Rabbit Model of Bacterial Meningitis (1999) (1)
Bacterial Peptidoglycan Transverses the Placenta to Induce Fetal Neuroproliferation and Aberrant Postnatal Behavior Graphical (2016) (1)
NOTES Autolysis-Resist ant Peptidoglycan ofAnomalous Composition inAmino-Acid-Starved Escherichia coli (1988) (1)
Initiation of Bacterial Killing by Two-Component Sensing of a “Death Peptide” (2003) (1)
Part B - Disease-Oriented Approach to the Discovery of Novel Vaccines (2003) (1)
Opening the OPK Assay Gatekeeper: Harnessing Multi-Modal Protection by Pneumococcal Vaccines (2019) (1)
Preparation of Purified Gram-positive Bacterial Cell Wall and Detection in Placenta and Fetal Tissues. (2016) (1)
Perspective of a Pediatrician: Shared Pathogenesis of the Three Most Successful Pathogens of Children (2020) (1)
Identification ofa Carbohydrate Recognition Domainin Filamentous Hemagglutinin fromBordetella pertussis (1993) (1)
Chapter 17 – Initiation of Bacterial Killing by Two-Component Sensing of a “Death Peptide”: Development of Antibiotic Tolerance in Streptococcus pneumoniae (2003) (1)
Faculty Opinions recommendation of Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release. (2003) (0)
Quinupristin-Dalfopristin Nonsusceptibility in Pneumococci from Sickle Cell Disease Patients (2007) (0)
Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit (2015) (0)
B-cell expansion as a precursor to splenic MZ lymphoma (MZ) and noncanonical NF-{kappa}B pathways generating marginal zone E{micro}-BCL10 mice exhibit constitutive activation of both canonical (2009) (0)
Bacterial TLR2/6 Ligands Block Ciliogenesis, Derepress Hedgehog Signaling, and Expand the Neocortex (2023) (0)
Critical Role of Hem1 in Hematopoietic Cell Chemotaxis and Innate Immunity to S. Pneumoniae (2006) (0)
PNEUMOCOCCAL-INDUCED MYOCARDIAL DYSFUNCTION: THE ROLE OF PLATELET ACTIVATING FACTOR RECEPTOR (PAFR) AND THE PHOSPHOLIPASE C (PLC) PATHWAY (2006) (0)
Transcytosis and Signalling of Pneumococci at the Blood Brain Barrier (2001) (0)
Erratum: Cutting edge: Combined treatment of TNF-α and IFN-γ causes redistribution of junctional adhesion molecule in human endothelial cells (Journal of Immunology (July 1)) (1999) (0)
Faculty Opinions recommendation of Triptans reduce the inflammatory response in bacterial meningitis. (2002) (0)
Book Review Meningococcal Disease Edited by Keith Cartwright. 316 pp. New York, John Wiley, 1995. $99.95. 0-471-95259-1 (1995) (0)
UNDERSTANDING MICROBIAL PATHOGENESIS AS A BASIS FOR VACCINE DESIGN (2003) (0)
Interactions between Cilia and Respiratory Pathogens (1990) (0)
Identiﬁcation of a Candidate Streptococcus pneumoniae Core Genome and Regions of Diversity Correlated with Invasive Pneumococcal Disease† (2006) (0)
Faculty Opinions recommendation of Genetic basis for activity differences between vancomycin and glycolipid derivatives of vancomycin. (2001) (0)
cerebrospinal fluid. measure drug concentrations in validation of an animal model used to cerebrospinal fluid and serum of rabbits: Pharmacokinetics of fluconazole in (2013) (0)
Chapter 30 – Pneumococcal Infections (2006) (0)
Preclinical alphavirus immunotherapy for NPM/ALK+ lymphoma in a mouse model (2005) (0)
NewlyMadeEnzymesDetermine Ongoing CellWallSynthesis and theAntibacterial Effects ofCellWallSynthesis Inhibitors (1986) (0)
Role of CCT{alpha} in Macrophage Secretion (2007) (0)
Cell-Specific Pathophysiology Bacterial Cell Wall into Host Cells and Innate Immunity: Uptake of Gram-Positive Platelet-Activating Factor Receptor and (2006) (0)
1 A Cross-reactive Protein Vaccine Combined with PCV-13 Prevents Streptococcus 2 pneumoniae– and Haemophilus influenzae– mediated Acute Otitis Media 3 (2019) (0)
Modulation ofBacteriolysis byCooperative Effects of Penicillin-Bindi ng Proteins laand3inEscherichia coli (1986) (0)
Phenotypic Tolerance Of Bacteria (2001) (0)
A pharmaceutical composition for inhibiting tilstoemningen of leukocytes to organs during sepsis or other trauma (1989) (0)
Role of CCTα in Macrophage Secretion (2007) (0)
Method Foer Inhibition of intraede of leukocyter i organ e.g. at blodfoergiftning. (1989) (0)
Commensal pneumococci go nuclear (2020) (0)
Faculty Opinions recommendation of The inhibitory effect of C-reactive protein on bacterial phosphorylcholine platelet-activating factor receptor-mediated adherence is blocked by surfactant. (2003) (0)
Genomics of the Conjunctival Pathogen Streptococcus pneumoniae (2013) (0)
BERACHING THE BLOOD-BRAIN BARRIER (1993) (0)
New insight on the pathogenesis and treatment of pneumococcal meningitis (1990) (0)
New Insights into Recombinant Pertussis Toxin (1993) (0)
Inhibition of white blood cells from flowing in organ in septicemia or other traumatic injury (1989) (0)
Pharmacokinetics ofFluconazole inCerebrospinal Fluid andSerumof Rabbits: Validation ofan AnimalModelUsedToMeasure DrugConcentrations inCerebrospinal Fluid (1994) (0)
Fetal neural progenitors process TLR signals from bacterial components to enhance proliferation and rework brain development (2021) (0)
INTRACELLULAR UPTAKE OF PNEUMOCOCCAL CELL WALL DEPRESSES CONTRACTILITY.: 114-T (2005) (0)
201 ETIOLOGY AND CLINICAL PRESENTATION OF MENINGITIS IN CHILDREN WITH CANCER. (2006) (0)

This paper list is powered by the following services:

Other Resources About Elaine Tuomanen

en.wikipedia.org

What Schools Are Affiliated With Elaine Tuomanen?

Elaine Tuomanen is affiliated with the following schools: